COMPARISON OF PORE-FORMING PEPTIDES FROM PATHOGENIC AND NONPATHOGENIC ENTAMOEBA-HISTOLYTICA

被引:34
|
作者
LEIPPE, M
BAHR, E
TANNICH, E
HORSTMANN, RD
机构
[1] Bernhard Nocht Institute for Tropical Medicine, Hamburg
关键词
AMOEBAPORE; MEMBRANE-ACTIVE PEPTIDE; AMPHIPATHIC HELIX; AMEBIASIS;
D O I
10.1016/0166-6851(93)90011-L
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Similar to the findings obtained with pathogenic Entamoeba histolytica, nonpathogenic isolates were found to kill mammalian cells in vitro, and cell extract caused pore formation in liposome membranes. A pore-forming peptide termed APnp was isolated from a nonpathogenic isolate using the schedule developed for the purification of APp or amoebapore, the homologous peptide of the pathogenic isolate HM-1:IMSS. Compared to APp, the specific activity of APnp in pore formation was 60% lower. cDNA sequencing indicated 95% identity of the primary structures of APnp and APp, and secondary structure predictions revealed a high degree of similarity. Notably, a glutamic acid residue at position 2 of APp is in APnp replaced by proline, which shortens one of the two amphipathic alpha-helices considered crucial for the pore-forming function. This structural divergence of the two peptides might explain the difference in their pore-forming activities.
引用
收藏
页码:101 / 110
页数:10
相关论文
共 50 条
  • [1] PORE-FORMING PEPTIDE OF PATHOGENIC ENTAMOEBA-HISTOLYTICA
    LEIPPE, M
    EBEL, S
    SCHOENBERGER, OL
    HORSTMANN, RD
    MULLEREBERHARD, HJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) : 7659 - 7663
  • [2] PRIMARY AND SECONDARY STRUCTURE OF THE PORE-FORMING PEPTIDE OF PATHOGENIC ENTAMOEBA-HISTOLYTICA
    LEIPPE, M
    TANNICH, E
    NICKEL, R
    VANDERGOOT, G
    PATTUS, F
    HORSTMANN, RD
    MULLEREBERHARD, HJ
    [J]. EMBO JOURNAL, 1992, 11 (10): : 3501 - 3506
  • [3] CHARACTERIZATION OF A MEMBRANE PORE-FORMING PROTEIN FROM ENTAMOEBA-HISTOLYTICA
    YOUNG, JDF
    YOUNG, TM
    LU, LP
    UNKELESS, JC
    COHN, ZA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (06): : 1677 - 1690
  • [4] PATHOGENIC VERSUS NONPATHOGENIC ENTAMOEBA-HISTOLYTICA
    MIRELMAN, D
    [J]. INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY, 1992, 1 (01): : 15 - 18
  • [5] ACTIVATION OF COMPLEMENT BY PATHOGENIC AND NONPATHOGENIC ENTAMOEBA-HISTOLYTICA
    REED, SL
    CURD, JG
    GIGLI, I
    GILLIN, FD
    BRAUDE, AI
    [J]. JOURNAL OF IMMUNOLOGY, 1986, 136 (06): : 2265 - 2270
  • [6] CYTOLYTIC AND ANTIBACTERIAL ACTIVITY OF SYNTHETIC PEPTIDES DERIVED FROM AMOEBAPORE, THE PORE-FORMING PEPTIDE OF ENTAMOEBA-HISTOLYTICA
    LEIPPE, M
    ANDRA, J
    MULLEREBERHARD, HJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2602 - 2606
  • [7] ADHERENCE OF PATHOGENIC AND NONPATHOGENIC ENTAMOEBA-HISTOLYTICA STRAINS TO NEUTROPHILS
    BURCHARD, GD
    BILKE, R
    [J]. PARASITOLOGY RESEARCH, 1992, 78 (02): : 146 - 153
  • [8] THE PORE-FORMING PEPTIDE OF ENTAMOEBA-HISTOLYTICA, THE PROTOZOAN PARASITE CAUSING HUMAN AMEBIASIS
    LEIPPE, M
    MULLEREBERHARD, HJ
    [J]. TOXICOLOGY, 1994, 87 (1-3) : 5 - 18
  • [9] GENOMIC DNA DIFFERENCES BETWEEN PATHOGENIC AND NONPATHOGENIC ENTAMOEBA-HISTOLYTICA
    TANNICH, E
    HORSTMANN, RD
    KNOBLOCH, J
    ARNOLD, HH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (13) : 5118 - 5122
  • [10] SPECIFIC LABELING OF CYSTEINE PROTEINASES IN PATHOGENIC AND NONPATHOGENIC ENTAMOEBA-HISTOLYTICA
    DEMEESTER, F
    SHAW, E
    SCHOLZE, H
    STOLARSKY, T
    MIRELMAN, D
    [J]. INFECTION AND IMMUNITY, 1990, 58 (05) : 1396 - 1401